Stock Fundamentals

Company Information

Company Name
Catalyst Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US14888U1016
CIK: 0001369568
CUSIP: 14888U101
Currency: USD
Full Time Employees: 182
Phone: 305 420 3200
Fiscal Year End: December
IPO Date: Nov 08, 2006
Description:

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Address:

355 Alhambra Circle, Coral Gables, FL, United States, 33134

Directors & Officers

Name Title Year Born
Mr. Patrick J. McEnany Co-Founder & Non-Executive Chairman 1947
Mr. Richard John Daly M.B.A. President, CEO & Director 1961
Mr. Michael W. Kalb CPA Executive VP, Treasurer & CFO 1971
Dr. Steven R. Miller Ph.D. Executive VP, COO & Chief Scientific Officer 1962
Mr. Jeffrey Del Carmen Executive VP & Chief Commercial Officer 1971
Dr. William T. Andrews FACP, M.D. Chief Medical Officer 1965
Ms. Mary Coleman VP & Head of Investor Relations NA
Mr. Brian Elsbernd J.D. Chief Compliance Officer & Chief Legal Officer 1964
Mr. Gregg Russo Chief Human Resources Officer 1963
Dr. Preethi Sundaram Ph.D. Chief Strategy Officer 1976

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 12, 2025 Molly Harper N/A Sale 26.75K $23.25 $621.84K
Nov 26, 2025 Carmen Jeffrey Del N/A Sale 10.98K $23.33 $256.23K
Sep 08, 2025 Brian Elsbernd N/A Sale 30.00K $20.30 $609.00K
Sep 04, 2025 Brian Elsbernd N/A Sale 30.00K $19.52 $585.60K
Sep 03, 2025 Brian Elsbernd N/A Sale 20.00K $20.08 $401.60K
Aug 27, 2025 David S Tierney N/A Sale 26.00K $20.20 $525.20K
Aug 26, 2025 Richard J Daly N/A Sale 22.97K $20.62 $473.64K
Aug 26, 2025 Steve Miller N/A Sale 115.00K $20.28 $2.33M
Jun 11, 2025 Preethi Sundaram N/A Sale 1.60K $26.42 $42.27K
Jun 10, 2025 Preethi Sundaram N/A Sale 2.32K $26.41 $61.38K
May 14, 2025 Gary Ingenito N/A Sale 44.00K $23.63 $1.04M
May 13, 2025 Gary Ingenito N/A Sale 200.00K $23.68 $4.74M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 18.77M Mar 31, 2026 15.35% $0.01 0.79%
Vanguard Group Inc 8.43M Dec 31, 2025 6.89% $0.00 -3.23%
State Street Corp 6.86M Mar 31, 2026 5.61% $0.01 -0.65%
American Century Companies Inc 4.14M Mar 31, 2026 3.38% $0.05 36.79%
Deerfield Management Co 3.94M Mar 31, 2026 3.22% $1.15 -19.70%
Dimensional Fund Advisors, Inc. 3.43M Mar 31, 2026 2.80% $0.02 14.46%
Bank of America Corp 3.04M Mar 31, 2026 2.48% $0.01 38.03%
Geode Capital Management, LLC 2.97M Mar 31, 2026 2.43% $0.00 2.48%
Morgan Stanley - Brokerage Accounts 2.69M Mar 31, 2026 2.20% $0.00 -8.39%
Renaissance Technologies Corp 2.35M Mar 31, 2026 1.92% $0.09 -11.42%
Royce & Associates, LP 2.09M Mar 31, 2026 1.71% $0.51 9.38%
HHG PLC 2.00M Mar 31, 2026 1.63% $0.02 16.23%
Boston Partners Global Investors, Inc 1.71M Mar 31, 2026 1.40% $0.04 39.00%
Charles Schwab Investment Management Inc 1.43M Mar 31, 2026 1.17% $0.01 5.41%
Northern Trust Corp 1.24M Mar 31, 2026 1.01% $0.00 2.13%
Kennedy Capital Management Inc 1.20M Mar 31, 2026 0.98% $0.63 -0.83%
UBS Group AG 986.09K Mar 31, 2026 0.81% $0.00 51.94%
The Goldman Sachs Group Inc 984.73K Mar 31, 2026 0.80% $0.00 0.53%
Arrowstreet Capital Limited Partnership 955.32K Mar 31, 2026 0.78% $0.01 -40.93%
Victory Capital Management Inc. 866.62K Mar 31, 2026 0.71% $0.01 -2.03%

Shares Statistics

Shares Outstanding: 122.38M
Shares Float: 115.58M
% Insiders: 557.30%
% Institutions: 8,932.90%
Short % Float: 7.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 7.04M 5.76% ▲ 0.02% Apr 30, 2026
2 Avantis US Small Cap Value ETF 3.81M 3.12% ▲ 0.00% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 3.73M 3.05% ▲ 0.35% Apr 30, 2026
4 Smithson Investment Trust Ord 3.36M 2.75% ▲ 0.00% Nov 30, 2025
5 iShares Russell 2000 ETF 2.73M 2.23% ▲ 0.85% Apr 30, 2026
6 State Street® SPDR® S&P® Biotech ETF 2.54M 2.07% ▼ 0.70% Apr 30, 2026
7 Vanguard Institutional Extnd Mkt Idx Tr 1.30M 1.07% ▲ 1.19% Apr 30, 2026
8 Fidelity Small Cap Index 1.13M 0.92% ▲ 1.13% Feb 28, 2026
9 Janus Henderson Hrzn Glb SC E2 USD 1.13M 0.92% ▼ 0.18% Mar 31, 2026
10 State Street SPDR Port S&P 600 Sm CpETF 1.06M 0.86% ▲ 0.03% Apr 30, 2026

Valuation Metrics

Enterprise Value: $3.07B
Trailing P/E: 18.08
Forward P/E: 12.87

Financial Highlights

Market Cap: $3.83B
EBITDA: $305.83M
P/E Ratio: $18.08
PEG Ratio: $0.00
Book Value: $8.29
Earnings/Share: $1.73
Profit Margin: 37.08%
Operating Margin: 49.02%
ROA (TTM): 16.27%
ROE (TTM): 24.50%
Revenue (TTM): $596.96M
Revenue/Share (TTM): $4.87
Earnings Growth (YOY): 11.10%
Revenue Growth (YOY): 5.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 6.08x 0.00x 0.14x N/A 0.00x
2024-12-31 5.17x 0.00x 0.15x N/A 0.00x
2023-12-31 2.88x 0.00x 0.17x N/A 0.00x
2022-12-31 5.57x 0.00x 0.20x 24.72x 0.00x
2021-12-31 7.76x 0.00x 0.13x 110.52x 0.01x
2020-12-31 7.00x 0.00x 0.12x 28.06x 0.00x
2019-12-31 4.62x 0.00x 0.22x 16.90x 0.01x
2018-12-31 5.80x 0.00x 0.16x -27.33x 0.00x
2017-12-31 19.97x 0.00x 0.05x -41.13x 0.00x
2016-12-31 19.79x 0.00x 0.06x -59.95x 0.00x
2015-12-31 17.41x 0.00x 0.08x -203.19x 0.00x
2014-12-31 7.49x 0.00x 0.20x -191.41x 0.00x
2013-12-31 11.83x 0.00x 0.16x -217.45x 0.00x
2012-12-31 10.16x 0.00x 0.13x -348.63x 0.00x
2011-12-31 7.47x 0.00x 0.40x -553.68x 0.00x
2010-12-31 19.32x 0.00x 0.05x -225.34x 0.00x
2009-12-31 26.81x 0.00x 0.04x -217.40x 0.00x
2008-12-31 8.33x 0.00x 0.12x -33.08x 0.00x
2007-12-31 54.51x 0.00x 0.02x N/A 0.00x
2006-12-31 26.64x 0.00x 0.04x N/A 0.00x
2005-12-31 2.25x 0.00x 0.43x N/A 0.00x
2004-12-31 2.71x 0.00x 0.37x N/A 0.00x
2003-12-31 N/A N/A N/A N/A 0.00x
2002-12-31 N/A 0.00x 0.60x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CPRX.US!